Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Thrombocytopenia 1Purpura, Thrombocytopenic, Idiopathic 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1

Interventions

posaconazole 2fludarabine 2Cyclophosphamide 2Busulfan 2fludarabine phosphate 1eltrombopag 1Thiotepa 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Micafungin 1Idarubicin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Decitabine 1Cytarabine 1Cholecalciferol 1Bone Marrow Transplantation 1Azacitidine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Myelodysplastic Syndromes × eltrombopag × Clear all
NCT01957176 2022-12-30

A Rollover Study to Provide Continued Treatment With Eltrombopag

Novartis

Phase 4 Completed
22 enrolled 9 charts
Classical hematologyMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myeloid, Acute, Purpura, Thrombocytopenic, Idiopathic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡